达格列净 (2S)-1,2-丙二醇水合物 T4460
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
1 mg | 960404-48-2 | ¥253.00 | 询底价 |
10 mg | 960404-48-2 | ¥863.00 | 询底价 |
2 mg | 960404-48-2 | ¥358.00 | 询底价 |
500 mg | 960404-48-2 | ¥6,950.00 | 询底价 |
1 mL | 960404-48-2 | ¥688.00 | 询底价 |
100 mg | 960404-48-2 | ¥3,190.00 | 询底价 |
50 mg | 960404-48-2 | ¥2,150.00 | 询底价 |
25 mg | 960404-48-2 | ¥1,430.00 | 询底价 |
5 mg | 960404-48-2 | ¥588.00 | 询底价 |
Product Introduction
Bioactivity
英文名: Dapagliflozin ((2S)-1,2-propanediol, hydrate)
描述: Dapagliflozin ((2S)-1,2-propanediol, hydrate) (BMS-512148 (2S)-1,2-propanediol, hydrate) 是 Dapagliflozin 1,2-propanediol, hydrate 的 S 型异构体,是竞争性葡萄糖协同转运蛋白2 抑制剂,可促进尿液中葡萄糖的排泄,可用于糖尿病的研究。它诱导 HIF1表达并减轻肾脏 IR 损伤。
体外活性: Dapagliflozin (2S)-1,2-propanediol, hydrate is the S-enantiomer of Dapagliflozin 1,2-propanediol, hydrate. Dapagliflozin inhibits sodium/glucose cotransporter 2 (SGLT2), which results in excretion of glucose into the urine.
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 50 mg/mL (99.41 mM)
关键字: Dapagliflozin ((2S) 1,2 propanediol, hydrate) | inhibit | Inhibitor | Dapagliflozin propanediol Monohydrate | Dapagliflozin propanediol | Sodium-dependent glucose cotransporters | SGLT | BMS-512148 1,2-propanediol, Hydrate | Dapagliflozin ((2S)1,2propanediol, hydrate) | Dapagliflozin (1,2-propanediol, hydrate)
相关产品: Ipragliflozin | KGA-2727 | Ertugliflozin | Dapagliflozin | Canagliflozin | Enavogliflozin | Licogliflozin | Leachianone A | Sotagliflozin | Sergliflozin A
相关库: Drug Repurposing Compound Library | Anti-Cancer Drug Library | Membrane Protein-targeted Compound Library | Anti-Metabolism Disease Compound Library | Inhibitor Library | GPCR Compound Library | Anti-Obesity Compound Library | Highly Selective Inhibitor Library | Anti-Cancer Approved Drug Library | EMA Approved Drug Library
达格列净 (2S)-1,2-丙二醇水合物 T4460信息由TargetMol中国为您提供,如您想了解更多关于达格列净 (2S)-1,2-丙二醇水合物 T4460报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途